Biochemical and Biophysical Research Communications, Vol.344, No.1, 30-36, 2006
Bromovinyl-deoxyuridine: A selective substrate for mitochondrial thymidine kinase in cell extracts
Cellular models of mitochondrial thymidine kinase (TK2) deficiency require a reliable method to measure TK2 activity in whole cell extracts containing two interfering deoxyribonucleoside kinases, thymidine kinase 1 (TK1) and deoxycytidine kinase. We tested the value of the thymidine analog (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) as a TK2-specific substrate. With extracts of OSTTK1(-) cells containing TK2 as the only thymidine kinase and a highly specific TK2 inhibitor we established conditions to detect the low TK2 activity commonly present in cells. With extracts of TK1-proficient osteosarcoma cells and normal human fibroblasts we showed that BVDU, but not 1-(beta-D-arabinofuranosyl)thymine (Ara-T), discriminates TK2 activity even in the presence of 100-fold excess TK1. A comparison with current procedures based on TK2 inhibition demonstrated the better performance of the new TK2 assay. When cultured human fibroblasts passed from proliferation to quiescence TK2 activity increased by 3-fold, stressing the importance of TK2 function ill the absence of TK1. (c) 2006 Elsevier Inc. All rights reserved.
Keywords:thymidine kinase 2;thymidine analogs;mitochondrial DNA precursors;TK2-deficiency;mitochondrial diseases;mitochondrial DNA depletion syndromes;enzyme assays;TK2 inhibitors